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Abstract In a study of seven di¡erent hsp60 species, we found
that all mammalian and microbial proteins shared the property
of eliciting an in£ammatory response in mouse macrophages. In
all cases, TNFK production was induced by 0.1 WM concentra-
tions of hsp60. However, the di¡erent hsp60 preparations did
not compete for the same binding site. The binding of £uores-
cence-labeled human hsp60 was inhibited by excess unlabeled
human, rat or mouse hsp60, but not hamster, Escherichia coli,
Chlamydia pneumoniae or Mycobacterium bovis hsp60. We
conclude that phylogenetically separate hsp60 species interact
with innate immune cells via di¡erent recognition pathways.
' 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Human heat shock protein 60 (hsp60) and several microbial
homologs have been reported to elicit a pro-in£ammatory
response in cells of the innate immune system. This response
includes the release of in£ammatory mediators such as IL-6,
TNFK and NO and the induction of the T helper cells type 1
promoting cytokines IL-12 and IL-15 [1^3]. These ¢ndings
suggest a role of hsp60 as a danger signal for the innate
immune system [2]. Recently, we have demonstrated the pres-
ence of a speci¢c binding receptor for human hsp60 on macro-
phages [4]. Binding of £uorescence-labeled human hsp60 was
found to be saturable, occurred with submicromolar a⁄nity
and could be competed by unlabeled human hsp60. Further-
more, our data indicate that the binding receptor for human
hsp60 is di¡erent from a common receptor for human hsp70,
hsp90 and gp96, recently identi¢ed as the K2-macroglobulin
receptor [4,5,6].
Hsp60 proteins are highly conserved throughout phylogeny,
as are other stress proteins, probably re£ecting their crucial
and uniform chaperone function in pro- and eukaryotic cells
[7]. However, it has not been determined whether all hsp60
species share the ability to activate innate immune cells, nor
whether they would employ the same recognition pathway.
We report here that all four mammalian and three microbial
hsp60 preparations are similarly potent in stimulating TNFK
production in mouse macrophages. However, only human, rat
and mouse hsp60 were found to compete for the same binding
site on mouse macrophages, suggesting di¡erential recognition
of phylogenetically hsp60 species.
2. Materials and methods
2.1. Cell cultures
The mouse macrophage cell lines J774A.1 (German Collection of
Microorganism and Cell Culture, Braunschweig, Germany) and
RAW264.7 (American Type Culture Collection, Manassas, VA,
USA) were cultured as previously described [4].
C3H/HeJ mice, expressing a functionally defective toll-like receptor
4 (TLR4) molecule and mice of the control strain C3H/HeN with the
complete functionally active TLR4 protein [8] were purchased from
Charles River (Wilmington, MA, USA). Bone marrow cells were ob-
tained by £ushing femurs and tibias with ice-cold phosphate-bu¡ered
saline (PBS). The cell suspension was washed by centrifugation
(500Ug, 5 min), and a total of 3.5U106 bone marrow cells was incu-
bated in tissue culture dishes with Pluznik medium [9]. After 6^7 days,
adherent bone marrow-derived macrophages (BMM) were detached
by incubation with ice-cold Ca2þ-, Mg2þ-free HBSS (Hank’s balanced
salt solution) for 10 min, followed by washing with HBSS (500Ug,
5 min), and were used for further studies.
2.2. Reagents
Recombinant human hsp60 was obtained from Peptor Ltd. (Reho-
vot, Israel) or StressGen Biotechnologies (Victoria, BC, Canada). Re-
combinant Chlamydia pneumoniae hsp60 was kindly provided by Dr.
T. Miethke (Institute for Medical Microbiology, Immunology and
Hygiene, Technical University of Munich, Munich, Germany). Re-
combinant mouse hsp60 and Mycobacterium bovis hsp65 were ob-
tained from the Department of Infectious Diseases and Immunology,
Faculty of Veterinary Medicine, Utrecht University, Utrecht, The
Netherlands [10]. Recombinant rat and Escherichia coli GroEL were
purchased from StressGen Biotechnologies. Recombinant hamster
hsp60 was obtained from IMMPACT Biotechnologies (Hamburg,
Germany). E. coli O26:B6 lipopolysaccharide (LPS), bovine serum
albumin (BSA) and ovalbumin (OVA) were from Sigma (Deisenhofen,
Germany). Endotoxin contents of the various substances were deter-
mined by quantitative limulus amebocyte lysate assay (BioWhittaker,
Verviers, Belgium). In human (Peptor Ltd. and StressGen Biotechnol-
ogies) and hamster hsp60 endotoxin contents were 9 1 EU/Wg protein
and in hsp60 proteins from rat, mouse, C. pneumoniae, E. coli and M.
bovis endotoxin contents were in the range of 0.008^0.1 EU/Wg protein
corresponding to 0.84^12 pg LPS equivalents/Wg protein. LPS con-
tained 0.01 EU/pg. The endotoxin content of hsp60 preparations
did not correlate with bioactivity. For the batches of human and
chlamydial hsp60 used here, controls using polymyxin B or heat treat-
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ment excluded that an endotoxin contamination accounts for bioac-
tivity [2,4,9,11]. The immunostimulatory oligonucleotide (ODN)1668
[9], containing a CpG motif, was purchased from Life Technologies
(Karlsruhe, Germany).
2.3. Protein labeling
Labeling of human hsp60 (Peptor Ltd.) with the £uorescence dye
Alexa488 was performed as previously described [4] using the Alexa
Fluor 488 Protein Labeling kit (Molecular Probes, Leiden, The Neth-
erlands).
2.4. Hsp60 binding and competition
Binding and competition assays were performed as previously de-
scribed [4]. Brie£y, after 2 days of continuous culture J774A.1 and
RAW264.7 cells were centrifuged (500Ug, 5 min, 4‡C) and resus-
pended in PBS/1% BSA (4‡C). Macrophages (1U106 cells/ml) were
incubated with 350 nM of the Alexa488-labeled human hsp60 for 45
min on ice for the binding studies. For the competition assays the
macrophages were preincubated with a 10-fold molar excess of the
unlabeled ligand for 30 min on ice. Then hsp60-Alexa488 was added
and the incubation was continued for another 45 min on ice. Subse-
quently, cells were washed with PBS/1% BSA and resuspended in
PBS/1% paraformaldehyde. The £uorescence signals of the samples
were quanti¢ed using a FACSCalibur £ow cytometer (BD Bioscience,
Rockville, CA, USA). Binding of Alexa488-labeled hsp60 was calcu-
lated using the geometric mean £uorescence value after subtracting
the auto£uorescence of the cells.
2.5. Stimulation of macrophages for TNFK and NO production
For the stimulation of TNFK or NO production, mouse macro-
phage cell lines and BMM were seeded (1U106 cells/ml) in the wells
of £at-bottom 96-well plates (200 Wl/well). After incubation for 18 h
(37‡C, 5% CO2), LPS, di¡erent hsp60 preparations or ODN1668 were
added to the macrophage cultures. After another 6 h (TNFK) or 24 h
(NO) of incubation, supernatants were collected. The amounts of
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Fig. 1. Pro-in£ammatory response in J774A.1 (A), RAW264.7 (B) or bone marrow-derived macrophages (C) stimulated with di¡erent mammali-
an and microbial hsp60 proteins. A,B: cells were incubated with medium alone or with medium supplemented with LPS (10 ng/ml) or with dif-
ferent hsp60 proteins (3 and 10 Wg/ml, corresponding to approximately 0.05 and 0.15 WM) as indicated. After 6 h of cultivation, the TNFK
concentrations in the cell supernatants were determined by ELISA. C: BMM from C3H/HeN (open bars) and C3H/HeJ (hatched bars) mice
were incubated with medium alone or with medium supplemented with LPS (1 ng/ml), di¡erent hsp60 proteins (3 and 10 Wg/ml) or ODN1668
(30 Wg/ml) as indicated. After 24 h of cultivation, the nitrite concentrations in the cell supernatants were determined by the Griess reaction.
The data represent the mean concentrations of TNFK+S.D. and of nitrite+S.D. of three independent experiments, each performed in triplicate.
h-hsp60, human hsp60; m-hsp60, mouse hsp60; r-hsp60, rat hsp60.
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(enzyme-linked immunosorbent assay; OptEIA mouse TNFK Set, BD
PharMingen, San Diego, CA, USA). The TNFK content was calcu-
lated using a standard curve obtained with recombinant mouse TNFK
[2]. NO released by macrophages was assessed by the determination of
accumulated nitrite in the culture supernatants by the colorimetric
Griess reaction [2].
3. Results
3.1. Macrophage stimulatory activity of di¡erent mammalian
and microbial hsp60 proteins
A prominent feature of macrophage activation by hsp60 is
the release of substantial amounts of TNFK within 4^6 h. We
therefore compared the production of TNFK after exposure of
the macrophages to the di¡erent hsp60 species at concentra-
tions of 3 and 10 Wg/ml for 6 h at 37‡C. LPS (10 ng/ml) was
used as positive control. Each of the four mammalian hsp60
species was found to elicit a TNFK response. When J774A.1
cells were exposed to human (Peptor Ltd. or StressGen Bio-
technologies), mouse, rat or hamster hsp60 comparable
amounts of TNFK (8.1^21.2 ng/ml) were induced in a dose-
dependent manner (Fig. 1A). TNFK secretion in response to
M. bovis hsp65, C. pneumoniae hsp60 or E. coli GroEL was
also dose-dependent and in the range of 2.8^18.4 ng/ml. In
parallel, we determined TNFK production in RAW264.7 cells
(Fig. 1B) after incubation with the di¡erent hsp60 proteins.
Again, all mammalian hsp60 species tested induced a dose-
dependent release of TNFK, with the lowest levels seen for rat
hsp60. Incubation with M. bovis hsp65, C. pneumoniae hsp60
or E. coli GroEL also induced the release of TNFK (2.2^19.0
ng/ml) in a dose-dependent manner. These results show that
rat, mouse and hamster hsp60 share pro-in£ammatory activity
with human hsp60. Furthermore, dose dependence and
amounts of TNFK released appear to be quite similar for
mammalian and microbial hsp60 proteins.
Most hsp60 species were also analyzed for the induction of
NO production. In all cases, dose-dependent NO production,
measured as nitrite, was observed. There was a stronger re-
sponse to human than to mouse, rat or microbial hsp60 spe-
cies (Fig. 1C). In the same experiment macrophages with
defective TLR4 receptor were analyzed. These cells were un-
responsive to each of the di¡erent hsp60 species, but not to a
TLR4-independent stimulus (Fig. 1C). We conclude that all of
the hsp60 species tested require an intact TLR4 for inducing a
pro-in£ammatory response.
3.2. Di¡erent hsp60 species do not share binding sites
The speci¢city of binding of the di¡erent hsp60 proteins to
the macrophage cell surface was analyzed by quantitative
competition experiments. Binding of £uorescence-labeled hu-
man hsp60 occurred to a similar degree in both mouse macro-
phage lines, J774A.1 and RAW264.7 (Fig. 2). A 10-fold molar
excess of OVA did not diminish binding, whereas an unla-
beled human hsp60 strongly competed for the binding site.
A similar extent of inhibition was observed for either of the
two macrophage lines. Mouse hsp60 was found to be a sim-
ilarly potent inhibitor as unlabeled human hsp60 (Fig. 3A).
This indicates that the binding site for human hsp60 on mouse
macrophages is identical with the receptor for self hsp60. Rat
hsp60 also competed with human hsp60 for binding (Fig. 3B).
By contrast, hamster hsp60 did not exhibit any cross-reactiv-
ity. Even at a 20-fold molar excess (7 Wmol/l) hamster hsp60
did not displace human hsp60 from the macrophage receptor
(Fig. 3C). Finally, E. coli GroEL as an example of microbial
hsp60 was also unable to inhibit the binding of human hsp60
(Fig. 3D).
A comparison of all hsp60 proteins analyzed is presented in
Fig. 4. In the experiments using J774A.1 macrophages (Fig.
4A), a di¡erent preparation of human hsp60 (from StressGen
Biotechnologies) caused inhibition of binding to a similar de-
gree as the original hsp60 protein (84% versus 82% inhibition).
Similar degrees of inhibition were also observed with mouse
hsp60 (78% inhibition) or rat hsp60 (70% inhibition), but not
with hamster hsp60 (15% inhibition). Also, preincubation of
J774A.1 cells with the same 10-fold molar excess of unlabeled
C. pneumoniae hsp60, M. bovis hsp65 or E. coli GroEL did
not interfere with the binding of human hsp60 (Fig. 4A). The
series of experiments was repeated with a second mouse mac-
rophage line, RAW264.7 (Fig. 4B). Essentially the same re-
sults were obtained, i.e. inhibition of the binding of Alexa488-
labeled human hsp60 was seen after preincubation of
Fig. 2. Speci¢c binding of human hsp60-Alexa488 to J774A.1 (A) or
RAW264.7 (B). Cells of the macrophage lines (1U106 cells/ml) were
preincubated for 30 min in the absence or presence of 3.5 WM unla-
beled human hsp60 or 3.5 WM OVA, followed by the addition of
350 nM human hsp60-Alexa488 for 45 min on ice. Fluorescence in-
tensities (x-axis) were plotted against cell counts.
Fig. 3. Di¡erential recognition of mammalian hsp60 and microbial
hsp60 by J774A.1 cells. Macrophages (1U106 cells/ml) were preincu-
bated for 30 min in the absence or presence of 3.5WM mouse hsp60
(A), 3.5 WM rat hsp60 (B), 3.5 WM and 7 WM hamster hsp60 (C),
3.5 WM E. coli GroEL (D) or 3.5 WM unlabeled human hsp60
(h-hsp60, panels C and D), followed by the addition of 350 nM hu-
man hsp60-Alexa488 for 45 min on ice. Fluorescence intensities
(x-axis) were plotted against cell counts.
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RAW264.7 cells with excess unlabeled human hsp60 from
Peptor Ltd. (59% inhibition), human hsp60 from StressGen
Biotechnologies (58% inhibition), mouse hsp60 (51% inhibi-
tion) or rat hsp60 (39% inhibition). Hamster hsp60 was not
available for this study. As with J77A.1 cells, excess unlabeled
C. pneumoniae hsp60, M. bovis hsp65 or E. coli GroEL did
not compete with hsp60-Alexa488 binding.
4. Discussion
The current study represents a ¢rst comparative analysis of
a large number of hsp60 species for their interaction with
innate immune cells. A ¢rst important observation was that
three di¡erent mammalian hsp60 proteins, from rat, mouse
and hamster, shared with human hsp60 the ability to elicit a
pro-in£ammatory response in macrophages, as determined by
the secretion of TNFK. The same outcome was noted for two
di¡erent mouse macrophage lines. We therefore conclude that
the ability to stimulate macrophage activity is a common
property of mammalian hsp60 species.
Interestingly, similar concentrations of the di¡erent mam-
malian hsp60 proteins were required to induce a TNFK re-
sponse, and this applied also to the three microbial hsp60
species tested. In general, the extent of macrophage activation,
as measured by the amounts of TNFK secreted, was compa-
rable between mammalian and microbial hsp60 proteins.
Most of the hsp60 preparations were also tested for the in-
duction of NO formation. Here, the response was also dose-
dependent, but human hsp60 was a better inductor than
mouse, rat or microbial hsp60. All hsp60 species tested re-
quired a functional TLR4 on macrophages for pro-in£amma-
tory activity. This observation extends similar ¢ndings re-
ported previously for human and chlamydial hsp60 [9,11^15].
In the second part of this comparative study binding prop-
erties of hsp60 to the macrophage membrane were analyzed.
These studies are based on our previous ¢ndings which
showed that binding of £uorescence-labeled human hsp60 to
mouse macrophages is concentration-dependent, saturable
and can be competed by submicromolar concentrations of
non-labeled human hsp60 [4]. Furthermore, binding of
hsp60 occurred in the absence of TLR4, which suggests that
TLR4 is essential for a pro-in£ammatory response but not for
initial binding [4].
We ¢nd here that mouse hsp60 is an equally potent inhib-
itor of binding to mouse macrophages as human hsp60. This
indicates that the receptor for self hsp60 on mouse macro-
phages recognizes with similar avidity mouse and human
hsp60. Rat hsp60 also showed cross-competition, and hence,
all three hsp60 species are recognized by the macrophage re-
ceptor for self hsp60.
By contrast, neither hamster hsp60 nor any of the three
microbial hsp60 were able to displace human hsp60 from its
receptor, despite a 10- or 20-fold molar excess of the inhibitor.
These data demonstrate some species restriction of the macro-
phage receptor for self hsp60. It seems probable that hamster
and microbial hsp60 proteins employ other sites of binding,
because all hsp60 species exhibit similar potency of inducing a
TNFK response, at similar concentrations. The homology of
amino acid sequences between mouse and microbial hsp60
species is around 50% whereas the homology between mouse
and other mammalian species is above 95%. Therefore, rela-
tively small di¡erences between mouse and hamster hsp60
must account for the lack of cross-reactivity.
Our ¢ndings are supported by recent reports that the rec-
ognition of hsp70 by innate immune cells follows similar rules,
i.e. human hsp70 does not share the binding site on innate
immune cells with mycobacterial hsp70 [16,17] although bind-
ing sites reside on the same membrane protein [18]. Because of
an important role of hsp60 in immunoregulation and the
abundance of hsp60 proteins in both, mammalian and micro-
bial cells, it may be mandatory for innate immune cells to
distinguish extracellular or cell surface hsp60 by their endog-
enous or infectious origin. Hsp60 has been suggested to func-
tion as a danger antigen to the innate immune system, when
released during cell necrosis at sites of in£ammation or when
released by microbial organisms [1,2,19]. In addition, hsp60
has been reported to deliver bound peptides to MHC pre-
sentation pathways upon endocytosis [20]. Taken together,
these ¢ndings suggest that hsp60 may provide a link between
innate and adaptive immunity, by facilitating peptide pre-
sentation and inducing co-stimulatory signals at the same
time. In this context it should be noted that it is currently
unknown whether the co-stimulatory activity of hsp60 is an
endogenous property or whether immunostimulatory com-
pounds such as LPS or lipopeptides are tightly bound by
the chaperone and ‘presented’ to the innate immune system.
Peptides presented by hsp60 include endogenous sequences of
the chaperone molecule itself. The latter appear to be primary
targets in several autoimmune diseases and have been found
to induce disease-regulatory cells [21^23]. The important role
of hsp60 epitopes in regulating self-tolerance and in£amma-
J774A.1A
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E. coli GroEL + hsp60*
M. bovis hsp65 + hsp60*
C. pneumoniae hsp60 + hsp60*
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mouse hsp60 + hsp60*
rat hsp60 + hsp60*
hsp60*
% maximal binding
0 25 50 75 100
hamster hsp60 + hsp60*
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human hsp60 (Peptor) + hsp60*
M. bovis hsp65 + hsp60*
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E. coli GroEL + hsp60*
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% maximal binding
RAW264.7B
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Fig. 4. Di¡erential recognition of mammalian hsp60 versus micro-
bial hsp60 by J774A.1 (A) and RAW264.7 (B). Cells of the macro-
phage lines (1U106 cells/ml) were preincubated for 30 min in the
absence or presence of di¡erent unlabeled hsp60 proteins (3.5 WM),
followed by the addition of 350 nM human hsp60-Alexa488
(hsp60*) for 45 min on ice. The analysis was performed by £ow cy-
tometry and the binding of hsp60* in the absence of any inhibitory
protein was set 100%.
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tory responses may render it advantageous that antigen pre-
senting cells are able to distinguish between self and microbial
hsp60. Indeed, it has been reported repeatedly that immuni-
zation with self versus microbial hsp60 or its peptides exerts
quite opposite e¡ects in animal models of autoimmune disease
[21,24^27].
Taken together, our data indicate similar pro-in£ammatory
potency of di¡erent mammalian and microbial hsp60 but no
common recognition mechanism. The latter may enable mac-
rophages to distinguish between self and potentially pathogen-
associated hsp60 proteins.
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